US2021123909A1PendingUtilityA1

Nanodiamond particles and related devices and methods

Assignee: DEBINA DIAGNOSTICS INCPriority: Sep 6, 2016Filed: Aug 6, 2020Published: Apr 29, 2021
Est. expirySep 6, 2036(~10.1 yrs left)· nominal 20-yr term from priority
G01N 21/6428G01N 33/587G01N 21/64G01N 33/533G01N 33/54346A61K 49/0065G01N 2800/226A61K 49/0056G01N 21/6489G01N 2201/0221G01N 21/6458G01N 33/558
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Nanodiamond particles and related devices and methods, such as nanodiamond particles for the detection and/or quantification of analytes, are generally described. In some embodiments, the device comprises a plurality of nanodiamond particles and a species bound to the nanodiamond particles. In certain embodiments, the plurality of nanodiamond particles may be exposed to a sample suspected of containing an analyte. In some cases, the analyte may bind to the species such that the presence of the analyte in the sample may be detected. In some embodiments, the devices, systems, and methods described herein are useful for the detection of an analyte in a sample obtained from a subject for, for example, diagnostic purposes. In some cases, the systems, devices, and methods described herein may be useful for diagnosing, prevent, treating, and/or managing a disease or bodily condition. In an exemplary embodiment, such systems, devices, and methods described herein may be useful for detecting and/or quantifying the presence of a virus (e.g., ebola) in a subject and/or a sample obtained from the subject.

Claims

exact text as granted — not AI-modified
1 . A diagnostic agent, said agent comprising a fluorescent nanodiamond particle chemically bonded to a polypeptide and/or polynucleotide. 
     
     
         2 . The diagnostic agent of  claim 1 , wherein the polypeptide is a disintegrin. 
     
     
         3 .- 4 . (canceled) 
     
     
         5 . The diagnostic agent of  claim 1 , wherein the fluorescent nanodiamond particle and the polypeptide are covalently bonded. 
     
     
         6 .- 31 . (canceled) 
     
     
         32 . A diagnostic agent as in  claim 1 , wherein the disintegrin is Bitistatin. 
     
     
         33 . (canceled) 
     
     
         34 . A diagnostic agent for detection of thrombotic events in a human or non-human animal, said agent comprising a fluorescent nanodiamond particle chemically bonded to disintegrin Bitistatin (Bt). 
     
     
         35 .- 36 . (canceled) 
     
     
         37 . The diagnostic agent of  claim 34 , wherein the fluorescent nanodiamond particle and the Bt are covalently bonded. 
     
     
         38 .- 46 . (canceled)

Join the waitlist — get patent alerts

Track US2021123909A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.